S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +0.31%
Nvidia 221.97 +2.25%
Microsoft 532.95 −0.11%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7121 +0.17%
CLOSED · 20:20 ET
Market ClerkRecap
Wed Oct 21 · markets closed2 signals today78 insider buys this week · $240.8MCIRO short report next: Oct 31The week ahead
SM
INSIDER · PTCT · PTC THERAPEUTICS, INC. · DIRECTOR

SCHMERTZLER MICHAEL

Every open-market transaction filed under this name, Aug 19 to Oct 14.

Filings
20
0 buys · 20 sells
Bought
—
open market, at cost
Sold
$6.6M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 14PTCTPTC THERAPEUTICS, INC.DirectorSell382$60.14$23K+4.6%
Oct 14PTCTPTC THERAPEUTICS, INC.DirectorSell2,118$59.52$126K+5.7%
Oct 7PTCTPTC THERAPEUTICS, INC.DirectorSell53$63.95$3K−1.6%
Oct 7PTCTPTC THERAPEUTICS, INC.DirectorSell2,447$63.38$155K−0.7%
Sep 17PTCTPTC THERAPEUTICS, INC.DirectorSell376$68.45$26K−8.1%
Sep 17PTCTPTC THERAPEUTICS, INC.DirectorSell9,624$67.83$653K−7.2%
Sep 16PTCTPTC THERAPEUTICS, INC.DirectorSell7,006$67.35$472K−6.6%
Sep 16PTCTPTC THERAPEUTICS, INC.DirectorSell2,994$66.58$199K−5.5%
Sep 10PTCTPTC THERAPEUTICS, INC.DirectorSell10,000$67.34$673K−6.6%
Sep 9PTCTPTC THERAPEUTICS, INC.DirectorSell572$68.67$39K−8.4%
Sep 9PTCTPTC THERAPEUTICS, INC.DirectorSell9,428$67.79$639K−7.2%
Aug 27PTCTPTC THERAPEUTICS, INC.DirectorSell610$72.22$44K−12.9%
Aug 27PTCTPTC THERAPEUTICS, INC.DirectorSell11,890$71.55$851K−12.1%
Aug 26PTCTPTC THERAPEUTICS, INC.DirectorSell5,626$73.18$412K−14.0%
Aug 26PTCTPTC THERAPEUTICS, INC.DirectorSell6,874$72.74$500K−13.5%
Aug 20PTCTPTC THERAPEUTICS, INC.DirectorSell691$72.92$50K−13.7%
Aug 20PTCTPTC THERAPEUTICS, INC.DirectorSell2,390$71.88$172K−12.5%
Aug 20PTCTPTC THERAPEUTICS, INC.DirectorSell9,419$70.78$667K−11.1%
Aug 19PTCTPTC THERAPEUTICS, INC.DirectorSell7,165$73.67$528K−14.6%
Aug 19PTCTPTC THERAPEUTICS, INC.DirectorSell5,335$72.86$389K−13.6%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.